Advisor Group Holdings, Inc. Adamis Pharmaceuticals Corp Transaction History

Advisor Group Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.1 - $0.3 $13 - $40	-136 Reduced 2.15%	6,191 $0
Q4 2022 Feb 10, 2023	SELL	$0.14 - $0.22 $540 - $850	-3,864 Reduced 37.92%	6,327 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.34 - $0.57 $850 - $1,424	-2,500 Reduced 19.7%	10,191 $5,000
Q1 2022 May 04, 2022	BUY	$0.55 - $0.73 $561 - $744	1,020 Added 8.74%	12,691 $7,000
Q3 2021 Nov 05, 2021	BUY	$0.92 - $1.18 $2,300 - $2,950	2,500 Added 27.26%	11,671 $11,000
Q2 2021 Aug 02, 2021	BUY	$0.66 - $1.23 $2,640 - $4,920	4,000 Added 77.35%	9,171 $10,000
Q1 2021 May 13, 2021	SELL	$0.54 - $1.79 $4,860 - $16,110	-9,000 Reduced 63.51%	5,171 $5,000
Q4 2020 Feb 10, 2021	BUY	$0.4 - $1.01 $3,560 - $8,989	8,900 Added 168.85%	14,171 $7,000
Q3 2020 Nov 12, 2020	SELL	$0.52 - $1.45 $1,508 - $4,205	-2,900 Reduced 35.49%	5,271 $4,000
Q1 2020 May 18, 2020	BUY	$0.33 - $0.89 $2,696 - $7,272	8,171 New	8,171 $3,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.